TAB2 ELISA kits are immunoassay tools for the measurement of the protein TGF-beta activated kinase 1 (MAP3K7) binding protein 2, which is encoded by the TAB2 gene in humans. Functionally, this protein is known to be involved in cardiac tissue development and autophagy pathways. The canonical protein structure is reported to have an amino acid sequence of 693 residues and a mass of 76.5 kDa. It is known to be localized in the membrane, lysosomes and cytoplasm and is widely expressed across many tissue types. As many as 2 protein isoforms have been reported. The protein has been noted to be post-translationally methylated, ubiquitinated and phosphorylated. The TAB2 gene has been associated with the disease, Congenital heart defects. Other alias names for this target include MAP3K7IP2, TGF-beta-activated kinase 1 and MAP3K7-binding protein 2, TAK1-binding protein 2, mitogen-activated protein kinase kinase kinase 7-interacting protein 2, and CHTD2.
The detection range for different TAB2 ELISA kits can vary, with some assays measuring target concentrations as low as 15.6 pg/mL and as high as 10 ng/mL. Click on the products below for more detailed ELISA kit information, such as target reactivity and assay sensitivity.